PL2538918T3 - Cytocholina do leczenia jaskry - Google Patents
Cytocholina do leczenia jaskryInfo
- Publication number
- PL2538918T3 PL2538918T3 PL11711656T PL11711656T PL2538918T3 PL 2538918 T3 PL2538918 T3 PL 2538918T3 PL 11711656 T PL11711656 T PL 11711656T PL 11711656 T PL11711656 T PL 11711656T PL 2538918 T3 PL2538918 T3 PL 2538918T3
- Authority
- PL
- Poland
- Prior art keywords
- citicoline
- glaucoma
- treatment
- Prior art date
Links
- RZZPDXZPRHQOCG-OJAKKHQRSA-M CDP-choline(1-) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OCC[N+](C)(C)C)O[C@H]1N1C(=O)N=C(N)C=C1 RZZPDXZPRHQOCG-OJAKKHQRSA-M 0.000 title 1
- 208000010412 Glaucoma Diseases 0.000 title 1
- 229960001284 citicoline Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM2010A000071A IT1398378B1 (it) | 2010-02-22 | 2010-02-22 | Citicolina per il trattamento del glaucoma e dell'ipertensione oculare. |
| PCT/IB2011/050663 WO2011101802A1 (en) | 2010-02-22 | 2011-02-17 | Citicoline for the treatment of glaucoma and ocular hypertension |
| EP11711656.6A EP2538918B1 (en) | 2010-02-22 | 2011-02-17 | Citicoline for the treatment of glaucoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2538918T3 true PL2538918T3 (pl) | 2015-05-29 |
Family
ID=42790833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11711656T PL2538918T3 (pl) | 2010-02-22 | 2011-02-17 | Cytocholina do leczenia jaskry |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8822429B2 (pl) |
| EP (1) | EP2538918B1 (pl) |
| JP (1) | JP5801324B2 (pl) |
| ES (1) | ES2528366T3 (pl) |
| IT (1) | IT1398378B1 (pl) |
| PL (1) | PL2538918T3 (pl) |
| WO (1) | WO2011101802A1 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20120284A1 (it) * | 2012-06-18 | 2013-12-19 | Omikron Italia S R L | Citicolina per il trattamento della retinopatia diabetica. |
| ITMI20121223A1 (it) * | 2012-07-13 | 2014-01-14 | Gregorio Fabio De | Nuova composizione farmacologica comprendente citicolina in combinazione con glicerolo e/o acetazolamide |
| JP6523958B2 (ja) * | 2012-09-28 | 2019-06-05 | タフツ・ユニバーシティ | ウリジン二リン酸誘導体、プロドラッグ、組成物およびそれらの使用 |
| WO2014160502A1 (en) | 2013-03-13 | 2014-10-02 | Tufts University | Uridine nucleoside derivatives, compositions and methods of use |
| ITUA20161679A1 (it) * | 2016-03-15 | 2017-09-15 | Neuraxpharm Italy S P A | Composizione per prevenire e trattare patologie neurodegenerative e disturbi cognitivi |
| IT201600103956A1 (it) * | 2016-10-17 | 2018-04-17 | Omikron Italia S R L | Formulazione oftalmica comprendente citicolina veicolata da liposomi per il trattamento del glaucoma |
| MX2023013266A (es) * | 2021-05-10 | 2023-12-15 | Omikron Italia S R L | Solucion oral basada en citicolina y nicotinamida para usar en el tratamiento del glaucoma. |
| IT202200021624A1 (it) * | 2022-10-20 | 2024-04-20 | Sifi Spa | Composizione nutraceutica ad effetto neuroprotettivo per il trattamento del glaucoma |
| WO2026009194A1 (en) | 2024-07-05 | 2026-01-08 | Fidia Farmaceutici S.P.A. | Pharmaceutical compositions for the prevention and/or treatment of degeneration of the optic nerve and retinal nerve cells resulting from glaucoma |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9303627D0 (sv) * | 1993-11-03 | 1993-11-03 | Kabi Pharmacia Ab | Method and means for prevention of cataract |
-
2010
- 2010-02-22 IT ITRM2010A000071A patent/IT1398378B1/it active
-
2011
- 2011-02-17 PL PL11711656T patent/PL2538918T3/pl unknown
- 2011-02-17 ES ES11711656.6T patent/ES2528366T3/es active Active
- 2011-02-17 WO PCT/IB2011/050663 patent/WO2011101802A1/en not_active Ceased
- 2011-02-17 US US13/580,181 patent/US8822429B2/en active Active
- 2011-02-17 EP EP11711656.6A patent/EP2538918B1/en active Active
- 2011-02-17 JP JP2012553433A patent/JP5801324B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| IT1398378B1 (it) | 2013-02-22 |
| EP2538918B1 (en) | 2014-11-19 |
| WO2011101802A1 (en) | 2011-08-25 |
| US20120316128A1 (en) | 2012-12-13 |
| EP2538918A1 (en) | 2013-01-02 |
| ITRM20100071A1 (it) | 2011-08-23 |
| JP5801324B2 (ja) | 2015-10-28 |
| ES2528366T3 (es) | 2015-02-09 |
| JP2013520406A (ja) | 2013-06-06 |
| US8822429B2 (en) | 2014-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201404121B (en) | Compositions for the treatment of dry eye | |
| EP2621499A4 (en) | METHODS OF TREATING ALLERGIC DISEASES | |
| ZA201403795B (en) | Formulations for the treatment of diabetes | |
| EP2646029A4 (en) | TREATMENT OF JAK2-MEDIATED DISEASES | |
| SG2014014724A (en) | METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS | |
| ZA201403430B (en) | 4-pregenen- 11ss -17 - 21-triols-3, 20- dione derivatives for the treatment of ocular conditions | |
| IL230960A0 (en) | A device for the treatment of eye disease | |
| IL225896A0 (en) | Treatment of mecp-2 related disorders | |
| IL231593B (en) | Buprenorphine for the treatment of acute suicidality | |
| IL230959A0 (en) | A device for the treatment of eye disease | |
| IL275636A (en) | Medical combination for cancer treatment | |
| HUP1100290A2 (en) | Combination compositions for the treatment of proliferative diseases | |
| IL234796B (en) | Compounds for the treatment of diseases related to ischemia-reperfusion | |
| PL2593423T3 (pl) | Proces wytwarzania środków kontrastowych | |
| ZA201400488B (en) | Compounds for the treatment of cancers associated with human papillomavirus | |
| PT2456445E (pt) | Agente para o tratamento de condições da pele | |
| IL236870B (en) | History of hydroxystatin for the treatment of osteoarthritis | |
| EP2531186A4 (en) | TREATMENT OF HAIR DRESSES | |
| IL232294A0 (en) | Preparations for the treatment of diabetes | |
| GB201207476D0 (en) | pharmaceutical for the treatment of leishmaniasis | |
| ZA201304121B (en) | Arlysulfonamide derivatives for the prevention or treatment of specific ophthalmologic disorders | |
| HK1188955A (en) | Methods for treating diseases of the retina | |
| GB201019158D0 (en) | Novel compounds and improved treatments for glaucoma | |
| GB201009094D0 (en) | Compounds for the treatment of closridium difficile-associated disease | |
| GB201110653D0 (en) | Composition for skin treatment |